Royalty Pharma plc (RPRX)
NASDAQ·Healthcare·Biotechnology
$53.74
-0.86%
Mkt Cap $23.32B
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (12 analysts)
$51.25
Range $45.00 – $61.00
Implied Upside
-4.6%
Consensus $51.25 vs current $53.74
NASDAQ·Healthcare·Biotechnology
$53.74
-0.86%
Mkt Cap $23.32B
Buy
6
Hold
0
Sell
0
Price Target (12 analysts)
$51.25
Range $45.00 – $61.00
-4.6%
Consensus $51.25 vs current $53.74